Late-preterm infants are generally born between 34 weeks and 36 weeks and six days of gestation. They are not as immature as babies born at much earlier gestations, but their lungs, nervous systems, immune defenses and metabolic control are still developing. Small-for-gestational-age infants, meanwhile, are smaller than expected for their gestational age, usually defined by a birth weight below the 10th percentile for a population-based reference. Some are constitutionally small but healthy; others have fetal growth restriction, a pathological condition in which the placenta or another maternal-fetal problem limits the delivery of oxygen and nutrients. The distinction is clinically crucial, yet it is not always easy to make at birth.

The central concern is that prematurity and impaired growth may place pressure on different physiological systems at the same time. A late-preterm infant may struggle to maintain body temperature, regulate blood glucose or coordinate sucking, swallowing and breathing. An infant affected by growth restriction may have reduced energy reserves, altered blood-vessel development and evidence of adaptation to a low-oxygen environment before birth. When these conditions coexist, the newborn may have less capacity to compensate for the challenges of early delivery. A baby who is both developmentally immature and nutritionally vulnerable could therefore require closer observation than birth weight or gestational age alone would suggest.

One of the most immediate risks is respiratory instability. Although surfactant production—the process that helps keep the tiny air sacs of the lungs open—improves rapidly during the final weeks of pregnancy, late-preterm lungs can still be less efficient than those of full-term newborns. Growth-restricted fetuses may also experience placental insufficiency, which can affect lung development and oxygen delivery. Together, these factors may increase the likelihood of breathing difficulties, oxygen supplementation or admission to a neonatal unit. Respiratory problems can in turn interfere with feeding, increase energy expenditure and make it harder for the infant to maintain stable blood chemistry.

Metabolic adaptation is another major concern. After the umbilical cord is cut, a newborn must rapidly shift from a continuous placental supply of glucose to an intermittent feeding-based energy system. Smaller infants have limited glycogen and fat stores, while late-preterm infants may not feed effectively because the neurological coordination required for safe oral feeding is still maturing. This combination can increase vulnerability to hypoglycaemia, in which blood glucose falls below the level needed by the brain and other organs. Without early detection and treatment, significant or prolonged hypoglycaemia can become a serious medical emergency, which is why at-risk babies are commonly monitored through repeated glucose measurements.

Temperature regulation presents a similar challenge. Newborns lose heat quickly because they have a large surface area relative to their body mass and limited ability to generate warmth through shivering. Small-for-gestational-age infants generally have less insulating fat, while late-preterm infants may have immature mechanisms for conserving heat. Hypothermia raises oxygen and glucose consumption, potentially creating a damaging cycle in which the infant burns scarce energy reserves simply to remain warm. The resulting metabolic stress may worsen feeding difficulties and respiratory instability, making routine care—skin-to-skin contact, thermal protection and timely feeding—an important part of risk reduction.

The longer-term implications are more complex and cannot be inferred from size or gestational age alone. Early growth restriction has been associated in many studies with changes in vascular biology, insulin sensitivity and later cardiometabolic health, although individual outcomes vary widely. Premature birth can affect neurodevelopment through altered brain maturation, neonatal illness and interruptions to normal sensory and nutritional experiences. When prematurity and restricted growth occur together, researchers are interested in whether their effects are merely additive or whether they interact, producing a risk greater than either exposure would create independently. That is the meaning behind the article’s provocative “double the risk?” framing, although the precise magnitude of risk must come from the underlying data and clinical context.

The causes of this overlap also matter. Late-preterm delivery may be spontaneous, follow premature rupture of the membranes or result from medical decisions made because continuing the pregnancy appears unsafe. Fetal growth restriction can arise from placental dysfunction, maternal hypertension, pre-eclampsia, infection, smoking, nutritional problems or fetal conditions. In some pregnancies, the same placental disease may contribute both to poor fetal growth and to an early delivery. This creates a challenge for researchers: an apparent association between the combined condition and poor outcomes may reflect not only gestational age and birth size, but also the underlying disease that led to delivery. Reliable studies must therefore account for factors such as maternal health, severity of growth restriction, sex, socioeconomic conditions and neonatal treatment.

For clinicians, the message is not that every late-preterm or small newborn will experience serious complications. Most infants in these groups do well, particularly when their needs are recognised early. The concern is that conventional labels can underestimate vulnerability when used in isolation. A late-preterm baby whose weight is also below the expected range may benefit from a more deliberate assessment of breathing, temperature, glucose control, feeding coordination and placental history. Care teams may need to decide carefully whether discharge is safe, since feeding and temperature problems can become apparent only after several hours. Parents may also need clear guidance on warning signs, feeding frequency and when urgent medical advice is required.

The report arrives at a time when neonatal medicine is increasingly focused on precision risk assessment rather than broad categories. Birth weight, gestational age, antenatal Doppler measurements, placental findings and early physiological observations could eventually be combined to identify infants who need additional monitoring while avoiding unnecessary intervention for those at low risk. The question posed by Greenough, Jenkinson and Hickey highlights why this approach matters: two apparently moderate risk factors may become more important when they appear together. As researchers continue to examine the interaction between early birth and restricted growth, the goal will be to translate that knowledge into safer delivery decisions, better newborn surveillance and support that protects vulnerable infants during the critical transition from womb to world.

Subject of Research: The combined health risks associated with late-preterm birth and being small for gestational age.

Article Title: Late preterm and small for gestational age – double the risk?

Article References: Greenough, A., Jenkinson, A. & Hickey, A. “Late preterm and small for gestational age – double the risk?” Pediatr Res (2026). https://doi.org/10.1038/s41390-026-05367-9

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41390-026-05367-9

Keywords: late preterm birth, small for gestational age, fetal growth restriction, neonatal health, hypoglycaemia, respiratory complications, newborn care, prematurity, placental insufficiency

Late preterm infants are typically born between 34 weeks and 36 weeks plus six days of gestation. They often appear stronger and more mature than very preterm babies, but their brains, hormone systems and feeding abilities are still developing. After birth, glucose levels can drop as the infant transitions from a constant placental supply to intermittent feeding. Immature glycogen stores, limited fat reserves, difficulty coordinating sucking and swallowing, and illness-related stress can all increase the risk of hypoglycemia.

Glucose is the brain’s primary energy source during early life, making neonatal hypoglycemia biologically concerning. When glucose delivery falls, the brain may initially compensate by using alternative fuels, including lactate and ketone bodies. If the shortage is severe, prolonged or repeatedly missed, however, energy production can become insufficient. This may interfere with neuronal signaling and, in extreme cases, contribute to cellular injury. The challenge is that many affected newborns show no obvious symptoms, while symptomatic infants may display only subtle signs such as jitteriness, poor feeding, lethargy, temperature instability or apnea.

The article by U. Felderhoff-Müser focuses attention on a crucial gap between immediate treatment and long-term certainty. Hospitals commonly screen infants considered vulnerable to hypoglycemia, including late preterm newborns, and intervene with feeding, buccal dextrose gel or intravenous glucose when indicated. These measures are designed to restore glucose quickly and prevent neurological stress. Yet the threshold used to define hypoglycemia is not a universal biological line. It is a clinical value shaped by gestational age, postnatal age, symptoms, measurement method and the balance between avoiding harm and preventing unnecessary intervention.

That uncertainty has made long-term follow-up essential. Researchers have investigated whether neonatal hypoglycemia is associated with later problems involving cognition, executive function, attention, language, motor coordination and school performance. Some studies have reported higher risks after severe, recurrent or prolonged episodes, while others have found limited or inconsistent effects, particularly when low glucose was detected and treated promptly. The differences may reflect more than glucose itself: prematurity, fetal growth restriction, maternal diabetes, infection, respiratory illness and socioeconomic conditions can independently influence neurodevelopment.

This is one reason the evidence remains difficult to interpret. Most long-term studies are observational, meaning researchers cannot randomly assign infants to experience different glucose levels. Instead, they compare children who had hypoglycemia with those who did not, while attempting to account for other medical and social factors. Even sophisticated statistical adjustments may not eliminate hidden confounding. In addition, studies use different definitions of hypoglycemia, different monitoring schedules and different ages or tools for developmental testing, making direct comparisons challenging.

The timing and pattern of low glucose may be as important as the lowest recorded number. A single short episode may carry a different biological significance from repeated episodes or an extended period below a treatment threshold. Continuous glucose monitoring has raised further questions by revealing fluctuations that intermittent heel-stick testing can miss, although sensor accuracy in newborns and the clinical meaning of every detected dip are still being evaluated. The emerging picture is therefore more complex than a simple division between “normal” and “abnormal.”

For clinicians and families, the practical message is not to dismiss hypoglycemia or to assume that every low reading predicts disability. Instead, the long-term evidence supports careful surveillance of infants at risk, rapid confirmation of abnormal results, and treatment strategies that protect the brain without disrupting feeding or exposing babies to unnecessary interventions. Developmental follow-up may be particularly important for infants with severe or recurrent episodes, neurological symptoms, or multiple additional risk factors. Such monitoring can identify difficulties early, when speech, occupational or educational support may have the greatest effect.

The discussion also underscores the need for better research. Future studies will need standardized glucose definitions, precise records of duration and recurrence, improved measurement technologies and follow-up extending into school age and adolescence. Researchers must also distinguish the effects of hypoglycemia from the conditions that caused it and examine outcomes beyond a single global developmental score. Felderhoff-Müser’s review places late preterm hypoglycemia in that broader scientific context: a common neonatal event whose immediate management is well established, but whose long-term consequences still demand careful, nuanced investigation.

Subject of Research: Late preterm hypoglycemia and its long-term neurodevelopmental evidence

Article Title: Late preterm hypoglycemia through the lens of long-term evidence

Article References: Felderhoff-Müser, U. “Late preterm hypoglycemia through the lens of long-term evidence.” Pediatric Research (2026). https://doi.org/10.1038/s41390-026-05316-6

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41390-026-05316-6

Keywords: late preterm infants, neonatal hypoglycemia, blood glucose, neurodevelopment, brain health, newborn care, long-term outcomes